King’s College London invites applications for a full-time Postdoctoral Researcher to validate and develop small molecule inhibitors that block candidalysin activity. You will work on fungal pathogenesis, epithelial cell biology, inhibitor screening and in vivo infection models to identify therapeutic candidates.
The role combines in vitro mechanistic studies with in vivo murine candidiasis models, guidance on compound prioritisation and data-driven Go/No-Go decisions, within a multidisciplinary
#J-18808-Ljbffr
Research Associate - Anti-Candidalysin Therapeutics employer: King's College London
At King’s College London, we pride ourselves on being an exceptional employer that fosters a collaborative and innovative work culture. Our commitment to employee growth is evident through comprehensive training opportunities and a supportive environment that encourages professional development. Located in the heart of London, our institution offers unique advantages such as access to world-class resources and a vibrant community dedicated to advancing research and education.
